Cardiorenal Syndrome Treatment Steps: Stabilizing Fluid Balance Before Anything Else

The third morning in hospital, a man in his seventies asked the question that unsettles almost everyone in his position. His ankles had finally shrunk back to something he recognized, his breathing was easier, and yet the nurse had just told him his kidney numbers had gone up. “So which one are you treating,” he asked, “my heart or my kidneys?” The honest answer was: the fluid between them.

That answer sits at the center of cardiorenal syndrome treatment steps. When the heart and kidneys start failing together, clinicians rarely have a single target to fix. What they have instead is a sequence: settle the fluid balance first, then keep the kidneys supplied with blood, then build the longer-term protection that keeps both organs from sliding again.

This explainer walks through that sequence in plain language, including the parts that still divide experts, so that the numbers on the whiteboard make more sense when you or someone you love is looking at them.

How cardiorenal syndrome treatment steps begin: fluid comes first

Cardiorenal syndrome is the medical term for a heart problem and a kidney problem that feed each other, so that a decline in one organ makes the other worse. Treating it is less like fixing a broken part and more like calming a feedback loop, and the first place clinicians usually interrupt that loop is fluid.

Here is why. A struggling heart pumps less blood forward, so the kidneys sense a drop in flow and respond exactly as they were designed to: they hold on to salt and water. That extra volume backs up into the veins, the lungs and the legs. Swollen, high-pressure veins then squeeze the kidneys from the outside, making it even harder for them to filter. The American Heart Association’s scientific statement on the condition describes this venous congestion, rather than low blood pressure alone, as one of the most important drivers of kidney injury in heart failure.

So the first practical step is a question: is this person overloaded, depleted, or a confusing mix of both? The answer decides everything that follows. Someone who is congested needs fluid removed. Someone who is dry after a long stretch of poor appetite and vomiting may need the opposite, at least briefly. Getting this wrong in either direction can push the kidneys further down.

Only once fluid is heading the right way does attention turn to blood pressure, then to the heart failure medicines that protect both organs over months and years, and finally, in a minority of cases, to machine-based fluid removal. The order is not rigid, and teams often work on two steps at once, but the logic is consistent: decongest, perfuse, protect.

Heart failure and kidney disease: why one organ drags the other down

The heart and kidneys share a circulation, a hormone system and a set of pressures, which is why trouble in one so reliably shows up in the other. Heart failure, meaning the heart cannot pump strongly enough or relax well enough to meet the body’s needs, affects more than six million adults in the United States according to the American Heart Association. Chronic kidney disease, meaning kidney damage or reduced filtering that lasts more than three months, is estimated by the NIH to affect roughly one in seven American adults. The overlap between the two groups is large.

Three mechanisms explain most of it. The first is flow: a weak pump delivers less blood to the kidneys. The second is pressure: congested veins raise the pressure inside the kidney, and because the kidney sits in a firm capsule, it cannot expand to relieve that pressure. The third is hormonal: the body’s stress systems, including the renin-angiotensin-aldosterone system, switch on to defend blood pressure, but in doing so they tighten blood vessels, retain salt and, over time, scar both heart muscle and kidney tissue.

The AHA statement notes that roughly one in four to one in three people hospitalized with acute heart failure develop some worsening of kidney function during the admission. That figure is worth keeping in mind, because it means a change in kidney numbers during treatment is common rather than exceptional, and its meaning depends entirely on context.

Understanding these links also explains why the treatment cannot simply be “more kidney care” or “more heart care” in isolation. A therapy that improves cardiac output often improves filtration too. A therapy that relieves venous pressure can do the same. The organs recover, when they recover, together.

The five types of cardiorenal syndrome, and why type 1 treatment looks different

Clinicians often sort cardiorenal syndrome into five types, a classification proposed by Ronco and colleagues and adopted in the AHA statement. The type describes which organ started the trouble and how quickly. It shapes the emphasis of treatment, even though the core steps overlap.

Type	What starts it	Typical pace	Treatment emphasis
1	Sudden worsening of heart failure injures the kidneys	Days	Urgent decongestion, protecting kidney blood flow
2	Long-standing heart failure gradually damages the kidneys	Months to years	Optimizing long-term heart medicines, slowing kidney decline
3	Sudden kidney injury strains the heart	Days	Treating the kidney cause, managing fluid and potassium
4	Chronic kidney disease drives heart disease	Years	Blood pressure, anemia and mineral control, cardiovascular protection
5	A body-wide illness, such as sepsis, hits both organs	Variable	Treating the underlying illness

Type 1 is the version most people meet in hospital: an acute heart failure admission during which the creatinine, a waste product measured in blood as a marker of kidney filtering, begins to climb. Cardiorenal syndrome type 1 treatment is where the “fluid first” principle is most visible, because congestion is usually the immediate problem and removing it is usually the immediate remedy.

Type 2 and type 4 are slower stories, managed in clinics over years. Here the steps are about protection rather than rescue: choosing medicines that shield both organs, controlling blood pressure and diabetes, and adjusting doses as kidney function changes. Types 3 and 5 are less about heart-failure strategy and more about finding and treating whatever set the kidneys, or the whole body, on fire.

The classification is a map, not a verdict. Many people move between types, and the AHA statement itself acknowledges that real patients rarely fit one box cleanly.

Step one: wet, dry, or both? How teams assess fluid status

Before anyone adjusts a medicine, the team needs a reasonably confident picture of how much fluid the body is carrying. This sounds simple. It is one of the hardest judgments in cardiology.

The bedside clues are familiar: swelling in the ankles or lower back, weight that has crept up over days, a need to sleep propped on pillows, crackles heard in the lungs, and stretched neck veins. Blood tests add detail. Natriuretic peptides, hormones the heart releases when it is stretched, rise with congestion. Creatinine and estimated glomerular filtration rate, or eGFR, a calculated estimate of how much blood the kidneys filter per minute, show how the kidneys are coping. Sodium and potassium levels warn about the safety margins for treatment.

Imaging fills the gaps. A chest X-ray can show fluid in the lungs. An echocardiogram, an ultrasound scan of the heart, reveals how well it pumps and relaxes and can estimate pressures inside it. Some teams use point-of-care ultrasound of the lungs and the large veins in the abdomen to judge congestion in minutes. In selected cases, particularly when the picture stays confusing, a catheter threaded into the heart’s right side can measure pressures directly.

The reason this step deserves its own heading is the trap of “both.” A person can have soaked lungs and swollen legs while the blood volume actually reaching the kidneys is low, because the weak heart is not moving it forward. The AHA statement describes this as congestion with poor perfusion, and it is the situation in which aggressive fluid removal alone can backfire. Recognizing it early changes the plan: fluid still needs to come off, but the heart may need support at the same time.

Step two: relieving congestion, and what diuretic resistance in heart failure means

Once congestion is confirmed, the workhorse treatment is a diuretic, a medicine that makes the kidneys pass more salt and water into the urine. The most commonly used class in heart failure is the loop diuretics, so named for the part of the kidney tubule they act on. In hospital they are often given intravenously, because a congested gut absorbs tablets poorly.

How much and how fast has been studied more carefully than people assume. The DOSE trial, published in the New England Journal of Medicine, compared higher versus lower intensity and continuous infusion versus intermittent injections in hospitalized heart failure patients. At 72 hours, neither comparison produced a clear difference in patients’ overall symptom scores or in change in kidney function, though the higher-intensity approach relieved breathlessness and shed more fluid, at the cost of a temporary rise in creatinine. The practical lesson clinicians drew is that a firm early response matters more than the precise delivery method, and that a modest creatinine bump during effective decongestion is not, by itself, a reason to stop.

Sometimes the kidneys stop answering. Diuretic resistance in heart failure describes a situation where the expected dose produces far less urine than it should. The causes include gut swelling that blunts absorption, kidney tubules that have adapted by growing more salt-retaining cells, low blood protein, and high salt intake quietly refilling the tank. Teams respond by measuring urine output and urine sodium within hours, confirming the medicine is actually reaching the kidney, and then, if needed, adding a second diuretic class that blocks a different part of the tubule. This “sequential blockade” is described in the AHA statement as a reasonable escalation. Every one of these adjustments is a prescribing decision that belongs to the treating clinician.

Step three: keeping the kidneys perfused when blood pressure is low

Pulling fluid off a congested body helps the kidneys only if enough blood still reaches them. Perfusion, meaning the delivery of blood to an organ, becomes the second preoccupation once decongestion is under way.

Blood pressure is the crude marker, but it is not the whole story. A person can have an acceptable pressure reading and still have kidneys starved of flow because the heart’s output is low and the veins are so congested that blood cannot drain through the organ. The AHA statement stresses that in cardiorenal syndrome, relieving venous pressure often improves filtration more than pushing arterial pressure up.

When pressure genuinely is too low to support the kidneys, teams have a few options, all used in monitored settings. Vasodilators, medicines that relax blood vessels, can reduce the load on a weak heart and improve forward flow when pressure allows. Inotropes, medicines that strengthen the heart’s contraction, are reserved for people with clear signs of low output such as cold extremities, confusion or falling urine, because they carry their own risks and have not been shown to improve long-term survival. Some long-term heart failure medicines that lower blood pressure may be paused briefly during this phase and restarted as the person stabilizes.

This is also the step where the team reviews everything else that might be harming the kidneys. Common culprits include anti-inflammatory painkillers, some antibiotics and contrast dye from scans. Removing avoidable insults is unglamorous but matters.

What patients notice at this stage is frequent checks: blood pressure, urine volume, daily blood tests. It can feel like nothing is happening. In fact the team is watching for the moment congestion falls, pressure holds and creatinine stops rising, which signals the loop has been interrupted.

Step four: heart failure medicines that also protect the kidneys

Once someone is no longer acutely congested, attention turns to the medicines that change the long-term course of heart failure. Clinicians call this guideline-directed medical therapy, a set of medicine classes shown in large trials to reduce hospitalizations and deaths. Several of them also slow kidney decline, which is why they sit at the heart of cardiorenal management.

The main classes, described here by mechanism rather than as recommendations:

• Medicines that block the renin-angiotensin system relax blood vessels, lower the pressure inside the kidney’s filters and reduce scarring in both organs. They often cause a small early drop in eGFR that stabilizes; the AHA statement and NHS guidance both note this is usually acceptable within limits set by the prescriber.
• Beta blockers slow the heart and dampen stress hormones, giving a weak heart time to fill and reducing its workload.
• Mineralocorticoid receptor antagonists block aldosterone, a hormone that retains salt and drives fibrosis. They require careful potassium monitoring when kidney function is reduced.
• SGLT2 inhibitors, originally diabetes medicines, make the kidneys pass glucose and sodium into the urine. Trials have shown reductions in heart failure hospitalization and slower kidney decline, which is why they now appear in heart failure and kidney disease guidelines regardless of diabetes status.

The catch is that most of these medicines affect kidney function or potassium, so introducing them when the kidneys are fragile is a matter of sequence and pace. Teams typically start one at a time, recheck blood tests within days to weeks, and adjust. People sometimes hear that a medicine was “held” and assume it failed; more often it is being timed. Whether, when and in what order any of these are used is entirely a decision for the prescribing clinician who can see the full picture.

Step five: ultrafiltration and dialysis, when fluid must be removed by machine

A minority of people with cardiorenal syndrome reach a point where diuretics, even in combination, cannot shift enough fluid. For them, the team may consider removing fluid mechanically.

Ultrafiltration is a procedure in which blood is drawn through a filter that removes water and salt at a controlled rate and returns the blood to the body. It is not the same as dialysis, because it does not clear the waste products that dialysis targets; it removes volume. The AHA statement summarizes the evidence honestly: trials comparing ultrafiltration with stepped diuretic strategies have given mixed results, with one large trial finding more kidney injury and complications in the ultrafiltration group. For that reason it is generally reserved for people who have genuinely failed medical decongestion, rather than used as a first-line shortcut.

Dialysis becomes the conversation when the kidneys can no longer clear waste, control potassium or acid, or handle fluid at all. It can be temporary, bridging a person through an acute illness while the kidneys recover, or it can become long-term if kidney function does not return. Both hemodialysis, filtering blood through a machine, and peritoneal dialysis, using the lining of the abdomen as a filter, are used in people with heart failure, and the choice depends on the heart’s tolerance of fluid shifts, vascular access and the person’s own preferences.

What patients often want to know is whether needing dialysis means the heart treatment has failed. It does not. Some people start temporary dialysis during a severe episode and come off it. Others live with both heart failure and long-term dialysis for years. The decision, its timing and its reversibility are individual, and the treating team is the right group to explain where a particular person stands.

Who is usually treated in hospital, and who is asked to wait or be monitored at home

Not everyone with heart failure and kidney disease needs an admission. The decision hinges on how quickly things are changing and how much reserve the person has left.

Hospital treatment is usually the path for people with acute type 1 syndrome: rapidly worsening breathlessness, swelling that has accelerated over days, a creatinine that has jumped rather than drifted, or blood pressure that is falling. Intravenous diuretics, frequent blood tests and the option of heart support are all easier to deliver safely on a ward. Signs of poor perfusion, such as confusion, cold limbs or very little urine, push the decision firmly toward admission, and sometimes toward intensive care.

People with the slower types are more often managed as outpatients. If someone with long-standing heart failure has a gradually declining eGFR but is stable, breathing comfortably and keeping a steady weight, the plan is typically a clinic-based one: reviewing medicines, tightening blood pressure and diabetes control, checking bloods every few weeks to months as the team sees fit, and teaching the person what changes warrant an early call.

There is also a group who are asked to wait before certain steps. Someone who is acutely unwell may be told that new long-term heart medicines will be started only once kidney function has settled. Someone whose creatinine is fluctuating may be asked to hold a planned procedure that involves contrast dye. Someone being considered for a device or transplant assessment may need the cardiorenal picture stabilized first. Waiting in these situations is not neglect; it is sequencing. The team is protecting the kidneys from an avoidable second hit while the first one heals.

What the following days and weeks usually look like

Recovery from an acute cardiorenal episode rarely follows a straight line, and knowing the usual shape of it can save a lot of anxiety.

In the first two to three days of hospital decongestion, the focus is on shifting fluid and watching the kidneys. Weight typically falls by a measurable amount each day, breathing eases before the legs slim down, and creatinine may drift up before it stabilizes. The DOSE trial’s 72-hour window reflects how clinicians think about this phase: it is the period in which they judge whether the strategy is working.

Toward the end of the admission, the team begins the transition to tablets and reviews which long-term medicines to restart or introduce. Discharge planning includes a target “dry weight,” the body weight at which the person is neither congested nor depleted, along with instructions for daily weighing, salt and fluid guidance, and a plan for blood tests. The American Heart Association advises people with heart failure to weigh themselves every morning after using the bathroom and to report gains of more than two to three pounds in a day or about five pounds in a week.

The first weeks at home are the vulnerable stretch. Kidney function often improves further as congestion clears, but it can also dip if fluid is removed too enthusiastically or intake falls. Early follow-up, ideally within the first week or two after discharge as heart failure programs commonly aim for, exists to catch these swings. Blood tests at that visit check creatinine and potassium, and medicines are adjusted accordingly.

Over the following months, if things go well, the story becomes one of optimization: medicine classes added one by one, cardiac rehabilitation, and a settling rhythm of clinic reviews. Setbacks happen, and a readmission is not a sign that the plan was wrong.

How to recover from heart failure when the kidneys are involved

People often ask how to recover from heart failure as though recovery were a single destination. With cardiorenal syndrome it is better understood as stabilizing two organs and then protecting them, and much of that protection happens at home.

Daily weighing is the single most useful habit, because a change on the scales usually shows up a day or two before symptoms do. Salt restriction matters because sodium drags water with it and quietly refills the fluid the hospital worked to remove; the NHS and Mayo Clinic both advise a lower-salt eating pattern for people with heart failure, with the specifics set by the care team. Fluid guidance varies by individual, and the amount that is right for one person can be harmful for another, so it should come from the team rather than a general rule.

Movement is protective. Cardiac rehabilitation, a supervised program of exercise, education and support after a heart event, is recommended in heart failure guidelines and has been studied in people with reduced ejection fraction who also have kidney impairment. The NHS describes rehab as a core part of heart failure care rather than an optional extra. Even short daily walks, built up gradually, help muscles use oxygen more efficiently and reduce the breathlessness that limits so many people.

Some medicines deserve a permanent caution. Over-the-counter anti-inflammatory painkillers reduce kidney blood flow and encourage salt retention, which is exactly the wrong combination. Anyone with cardiorenal syndrome should check with a pharmacist or clinician before taking any new medicine or supplement.

Vaccinations against influenza, pneumococcal disease and COVID-19 reduce the infections that commonly tip a stable person into decompensation, a sudden worsening of heart failure. Sleep, mood and alcohol all feed into stability too. None of this replaces the medicines; all of it makes the medicines work better.

What people often get wrong about cardiorenal syndrome treatment steps

Several myths circulate around this condition, and a few of them can actively cause harm.

“Rising creatinine means the diuretics are damaging my kidneys, so they should stop.” Not necessarily. The AHA statement distinguishes a modest, transient creatinine rise during effective decongestion, which is often hemodynamic and reversible, from true kidney injury. In several analyses, people whose creatinine rose while they were successfully decongested did no worse than those whose creatinine stayed flat. The team weighs the whole picture; the number alone does not decide.

“Drinking more water will flush my kidneys.” In most kidney conditions this is harmless. In cardiorenal syndrome it can refill the congestion that is squeezing the kidneys. Fluid intake should follow the team’s guidance.

“There is one best treatment for cardiorenal syndrome.” There is not. What are the treatment guidelines for cardiorenal syndrome? Honestly, there is no single dedicated guideline with a fixed algorithm. Care draws on heart failure guidelines from cardiology societies, kidney disease guidelines, and the AHA scientific statement, and it is individualized around fluid status, blood pressure and kidney function. Anyone promising a protocol that works for everyone is oversimplifying.

“Machine fluid removal is more effective than medicines.” The trial evidence, as summarized by the AHA, is mixed and does not support ultrafiltration as a routine first choice.

“Kidney damage from heart failure is permanent.” Often it is not. Filtration frequently improves as congestion clears, sometimes over weeks. Some people do have lasting chronic kidney disease, and the team will say so if that is the case, but a bad number during an acute episode is not a life sentence.

“Once I feel better I can ease off the medicines.” Long-term heart failure medicines work by preventing the next episode, not by treating the current symptoms. Stopping or changing any of them without the prescriber’s guidance is one of the most common reasons people return to hospital.

Questions to ask your care team

The whiteboard numbers make far more sense when you know which questions unlock them. Consider asking:

• Am I currently overloaded with fluid, depleted, or somewhere in between, and how are you judging that?
• Which type of cardiorenal syndrome do you think this is, and what does that mean for the order of treatment?
• My creatinine went up. Is that the expected kind of change during decongestion, or are you worried it is true kidney injury?
• What is my target dry weight, and what weight change should make me call you?
• Which of my usual medicines are being paused, why, and when do you expect to restart them?
• Which long-term heart failure medicine classes are you planning to introduce, in what order, and what blood tests will you check afterward?
• Are there medicines I already take, including over-the-counter ones and supplements, that could be harming my kidneys?
• How much fluid and salt is right for me specifically?
• Is machine-based fluid removal or dialysis being considered, and if so, is it likely to be temporary?
• Am I a candidate for cardiac rehabilitation, and how do I access it?
• When is my first follow-up appointment, and who do I contact if something changes before then?
• What symptoms should send me to the emergency department rather than the clinic?

It helps to bring a written list of every medicine and supplement, a record of recent daily weights if you have them, and a family member or friend who can take notes. Ask for the team’s answers in plain words, and ask again if they do not land the first time. Clinicians managing this condition are making judgment calls with incomplete information, and most welcome a patient who understands the reasoning rather than just the instructions.

When to call your doctor

Cardiorenal syndrome can shift quickly, and the signals that matter most are the ones that show up before you feel truly unwell. Contact your heart failure or kidney team promptly, the same day, if you notice any of the following:

• Weight gain of more than two to three pounds in a single day or about five pounds in a week, as the American Heart Association advises for people with heart failure.
• New or worsening swelling of the ankles, legs or abdomen, or clothes and shoes that suddenly feel tight.
• Breathlessness that is worse than usual, a new need to sleep on more pillows, or waking at night short of breath.
• A noticeable fall in how much urine you pass, or urine that has become very dark.
• Dizziness on standing, unusual fatigue or feeling faint, which can signal that fluid has been removed too far or blood pressure has dropped.
• Persistent vomiting or diarrhea, which quickly upsets fluid and potassium balance in someone on diuretics.
• A new cough, fever or other infection, since infections commonly trigger decompensation.

Call emergency services or go to the nearest emergency department without waiting if you have chest pain or pressure, severe breathlessness at rest, fainting, confusion or new drowsiness, a racing or very irregular heartbeat, or you are producing almost no urine. These can indicate a dangerous drop in the heart’s output, a serious rhythm problem or acute kidney failure, all of which need immediate assessment.

Between those extremes sits a large gray zone, and the right instinct is to call rather than wait. Heart failure teams expect these calls and would far rather adjust a plan early than meet you again on a ward. Every decision about your medicines, your fluid targets and your next step belongs to the clinicians who know your history; this article is here to help you understand the conversation, not to replace it.

Frequently asked questions

What is the best treatment for cardiorenal syndrome?

There is no single best treatment; care is sequenced around fluid balance. Most people are first decongested with diuretics, then kept adequately perfused, then moved onto long-term heart failure medicine classes that protect both organs. Machine-based fluid removal is reserved for those who do not respond. The right combination and order depend on the type of syndrome and are decided by the treating team.

What are the treatment guidelines for cardiorenal syndrome?

No dedicated guideline sets a fixed algorithm. Clinicians draw on heart failure guidelines from cardiology societies, chronic kidney disease guidelines, and the American Heart Association scientific statement on cardiorenal syndrome, which describes decongestion, perfusion, medicine optimization and when to consider ultrafiltration or dialysis. Because evidence is still developing in several areas, care is individualized rather than protocol-driven.

What is cardiorenal syndrome type 1 treatment?

Type 1 is sudden heart failure worsening that injures the kidneys, and treatment centers on urgent decongestion with intravenous diuretics while protecting kidney blood flow. Teams track daily weight, urine output and blood tests, add a second diuretic class if the response is poor, and pause or restart long-term heart medicines as blood pressure and kidney function allow. Ultrafiltration is considered only if medical treatment fails.

How is diuretic resistance in heart failure managed?

Clinicians first confirm the medicine is reaching the kidney, often by switching from tablets to intravenous delivery and measuring urine sodium within hours. If output stays low, they may add a diuretic that works on a different part of the kidney tubule, review salt intake and check for low blood protein. These are prescribing decisions for the treating clinician, made with close monitoring of kidney function and potassium.

How are heart failure and kidney disease connected?

They share circulation, pressures and hormones. A weak heart reduces blood flow to the kidneys, congested veins raise pressure inside them, and stress hormones released to defend blood pressure retain salt and scar both organs over time. That is why heart failure so often coexists with chronic kidney disease and why treatments that help one organ frequently help the other.

Does a rising creatinine mean my kidneys are being damaged?

Not always. A modest, temporary creatinine rise during effective fluid removal is often a pressure-related change that reverses as congestion clears, and the AHA statement distinguishes it from true kidney injury. The team looks at the size of the change, your urine output, blood pressure and symptoms together. Only they can judge whether a particular rise is expected or concerning.

How to recover from heart failure when the kidneys are also affected?

Recovery means stabilizing both organs and then protecting them. Daily morning weighing, a lower-salt pattern and fluid guidance set by your team, taking long-term heart failure medicines as prescribed, avoiding over-the-counter anti-inflammatory painkillers, staying vaccinated and joining cardiac rehabilitation all reduce the chance of another episode. Kidney function often improves over weeks as congestion resolves.

What are the treatment options for chronic kidney disease in someone with heart failure?

Options overlap heavily with heart failure care: controlling blood pressure and diabetes, using medicine classes that protect both organs such as renin-angiotensin blockers and SGLT2 inhibitors where appropriate, managing anemia and mineral balance, avoiding kidney-toxic medicines, and planning for dialysis only if filtering falls very low. Which options suit an individual is a decision for the nephrology and cardiology teams together.

Is ultrafiltration better than diuretics for removing fluid?

The evidence does not show that. Trials comparing ultrafiltration with stepped diuretic strategies have given mixed results, and one large trial found more kidney injury and complications with ultrafiltration. The AHA statement therefore describes it as an option for people who have genuinely failed medical decongestion rather than a routine first-line treatment.

Will I need dialysis permanently if it is started during a heart failure admission?

Not necessarily. Dialysis started during a severe acute episode is sometimes temporary, bridging the person while the kidneys recover as congestion and blood flow improve. Some people do progress to long-term dialysis if kidney function does not return. Your kidney team can explain which situation applies to you and how they will assess recovery over the following weeks.

References

• Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies. AHA Scientific Statement (PubMed)
• Diuretic strategies in patients with acute decompensated heart failure (DOSE trial), New England Journal of Medicine (PubMed)
• Heart failure: Treatment, NHS
• Chronic Kidney Disease (CKD), NIH National Institute of Diabetes and Digestive and Kidney Diseases

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.